Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas
| Image |  |
|---|---|
| Description | scientific article published in March 2002 |
| Author/s |
author: David A Reardon Allan Friedman Darell D. Bigner Jennifer J Quinn Gamal Akabani Xiao-Guang Zhao R. Edward Coleman Charles N Pegram James M Provenzale Ilkcan Cokgor Henry Seth Friedman James H. Herndon Michael R Zalutsky Jeremy N Rich Roger E McLendon Carol J Wikstrand |
| Publication date | March 1, 2002 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |